Sana Biotechnology
NASDAQ: SANA
Developing cell and gene therapies for complex diseases.
Developing cell and gene therapies for complex diseases.
Sector
Life SciencesCategory
TherapeuticsLocation
Cambridge, MAInitial Investment
2018
Sana Biotechnology, Inc. (NASDAQ: SANA) is focused on creating and delivering engineered cells as medicine for patients. We are a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and changes how we approach treating disease.